Interpace Biosciences rises as probe finds no evidence of illegal acts

Interpace Biosciences

14/10/2020 12:51

** Diagnostic test maker's  IDXG.O  shares rise 11.7% to
$3.33 premarket
    ** Co says an audit committee found that allegations
regarding certain employment, billing and compliance matters
were unsubstantiated and that there was no evidence of any
illegal acts  urn:newsml:reuters.com:*:nGNX1Jmtqy
    ** On Aug.17, IDXG shares fell over 19% after audit
committee started the probe and led to delay in filing qtrly
report  urn:newsml:reuters.com:*:nL4N2FJ2DK
    ** Stock down 40% this year, as of last close

 (Reporting By Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))